Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment­Refractory Nontuberculous Mycobacterial Lung Disease.

Rubino, Christopher M; Onufrak, Nikolas J; van Ingen, Jakko; Griffith, David E; Bhavnani, Sujata M; Yuen, Dayton W; Mange, Kevin C; Winthrop, Kevin L

Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with TreatmentRefractory Nontuberculous Mycobacterial Lung Disease.

Rubino, Christopher M; Onufrak, Nikolas J; van Ingen, Jakko; Griffith, David E; Bhavnani, Sujata M; Yuen, Dayton W; Mange, Kevin C; Winthrop, Kevin L.

Afiliação

Rubino CM; Institute for Clinical Pharmacodynamics, Inc, 242 Broadway, Schenectady, NY, USA. crubino@icpd.com.
Onufrak NJ; Institute for Clinical Pharmacodynamics, Inc, 242 Broadway, Schenectady, NY, USA.
van Ingen J; Department of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands.
Griffith DE; The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX, USA.
Bhavnani SM; National Jewish Health, 1400 Jackson St, Denver, CO, 80206, USA.
Yuen DW; Institute for Clinical Pharmacodynamics, Inc, 242 Broadway, Schenectady, NY, USA.
Mange KC; Insmed Incorporated, 700 US-206, Bridgewater, NJ, USA.
Winthrop KL; Insmed Incorporated, 700 US-206, Bridgewater, NJ, USA.

Eur J Drug Metab Pharmacokinet ; 46(4): 573-574, 2021 Jul.

Article em En | MEDLINE | ID: mdl-33871806

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article